Clinical implications of epigenetic alterations in human thoracic malignancies: Epigenetic alterations in lung cancer

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 221-239

  Shinjo, Keiko ^a   Kondo, Yutaka ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

CpG island methylator phenotype; Demethylating agent; DNA methylation; Epithelial growth factor receptor; High throughput methylation analysis; Histone deacetylase; Lung cancer; Non small cell lung cancer; Small cell lung cancer

Indexed keywords

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CPG ISLAND; DNA METHYLATION; DNA REPAIR; EPIGENETICS; GENETIC EPIGENESIS; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METHODOLOGY; MUTATION; PHYSIOLOGY;

APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CPG ISLANDS; DNA METHYLATION; DNA REPAIR; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; MUTATION;

EID: 84859986057     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_13     Document Type: Article

References (100)

1. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010, CA Cancer J. Clin. 60, 277-300.
2. Ferlay, J., Parkin, D. M., and Steliarova-Foucher, E. (2010) Estimates of cancer incidence and mortality in Europe in 2008, Eur J Cancer 46, 765-781.
3. Mok, T. S., Wu, Y. L., Thongprasert, S., Yang, C. H., Chu, D. T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., Nishiwaki, Y., Ohe, Y., Yang, J. J., Chewaskulyong, B., Jiang, H., Duffi eld, E. L., Watkins, C. L., Armour, A. A., and Fukuoka, M. (2009) Gefi tinib or carboplatinpaclitaxel in pulmonary adenocarcinoma, N. Engl. J. Med. 361, 947-957.
4. Mitsudomi, T., Morita, S., Yatabe, Y., Negoro, S., Okamoto, I., Tsurutani, J., Seto, T., Satouchi, M., Tada, H., Hirashima, T., Asami, K., Katakami, N., Takada, M., Yoshioka, H., Shibata, K., Kudoh, S., Shimizu, E., Saito, H., Toyooka, S., Nakagawa, K., and Fukuoka, M. (2010) Gefi tinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial, Lancet Oncol 11, 121-128.
5. Choi, Y. L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., Ishikawa, Y., Kimura, H., Mitsudomi, T., Tanio, Y., and Mano, H. (2010) EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors, N. Engl. J. Med. 363, 1734-1739.
6. Belinsky, S. A. (2004) Gene-promoter hypermethylation as a biomarker in lung cancer, Nat Rev Cancer 4, 707-717. (Pubitemid 39215069)
7. Jones, P. A., and Laird, P. W. (1999) Cancer epigenetics comes of age, Nat. Genet. 21, 163-167. (Pubitemid 29070360)
8. Jones, P. A., and Baylin, S. B. (2007) The epigenomics of cancer, Cell 128, 683-692. (Pubitemid 46273572)
9. Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glockner, S., Piantadosi, S., Gabrielson, E., Pridham, G., Pelosky, K., Belinsky, S. A., Yang, S. C., Baylin, S. B., and Herman, J. G. (2008) DNA methylation markers and early recurrence in stage I lung cancer, N. Engl. J. Med. 358, 1118-1128. (Pubitemid 351398486)
10. Shen, L., Catalano, P. J., Benson, A. B., 3rd, O'Dwyer, P., Hamilton, S. R., and Issa, J. P. (2007) Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fl uorouracil based chemotherapy, Clin. Cancer Res. 13, 6093-6098. (Pubitemid 350075067)
11. Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., Verhaak, R. G., Hoadley, K. A., Hayes, D. N., Perou, C. M., Schmidt, H. K., Ding, L., Wilson, R. K., Van Den Berg, D., Shen, H., Bengtsson, H., Neuvial, P., Cope, L. M., Buckley, J., Herman, J. G., Baylin, S. B., Laird, P. W., and Aldape, K. (2010) Identifi cation of a CpG Island Methylator Phenotype that Defi nes a Distinct Subgroup of Glioma, Cancer Cell 17, 510-522.
12. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., and Belinsky, S. A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum, Cancer Res. 60, 5954-5958.
13. Laird, P. W. (2010) Principles and challenges of genome-wide DNA methylation analysis, Nat. Rev. Genet. 11, 191-203.
14. Brauch, H., Johnson, B., Hovis, J., Yano, T., Gazdar, A., Pettengill, O. S., Graziano, S., Sorenson, G. D., Poiesz, B. J., Minna, J. (1987) Molecular analysis of the short arm of chromosome 3 in small-cell and non-smallcell carcinoma of the lung, N. Engl. J. Med. 317, 1109-1113. (Pubitemid 17156740)
15. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., and Nakamura, Y. (1992) Three distinct regions involved in 3p deletion in human lung cancer, Oncogene 7, 445-449.
16. Zabarovsky, E. R., Lerman, M. I., and Minna, J. D. (2002) Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers, Oncogene 21, 6915-6935. (Pubitemid 35221938)
17. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. (1989) p53: A frequent target for genetic abnormalities in lung cancer, Science 246, 491-494. (Pubitemid 19273938)
18. Forbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., Teague, J. W., Stratton, M. R., and Futreal, P. A. (2010) COSMIC (the Catalogue of Somatic Mutations in Cancer): A resource to investigate acquired mutations in human cancer, Nucleic Acids Res 38, D652-657.
19. Wistuba, II, Gazdar, A. F., and Minna, J. D. (2001) Molecular genetics of small cell lung carcinoma, Semin. Oncol. 28, 3-13. (Pubitemid 32730372)
20. Mounawar, M., Mukeria, A., Le Calvez, F., Hung, R. J., Renard, H., Cortot, A., Bollart, C., Zaridze, D., Brennan, P., Boffetta, P., Brambilla, E., and Hainaut, P. (2007) Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history, Cancer Res. 67, 5667-5672. (Pubitemid 46984998)
21. Kosaka, T., Yatabe, Y., Endoh, H., Kuwano, H., Takahashi, T., and Mitsudomi, T. (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications, Cancer Res. 64, 8919-8923. (Pubitemid 39665498)
22. Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, II, Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., Fujisawa, T., Feng, Z., Roth, J. A., Herz, J., Minna, J. D., and Gazdar, A. F. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers, J Natl. Cancer Inst. 97, 339-346. (Pubitemid 40425952)
23. Sharma, S. V., Bell, D. W., Settleman, J., and Haber, D. A. (2007) Epidermal growth factor receptor mutations in lung cancer, Nat Rev Cancer 7, 169-181.
24. Le Calvez, F., Mukeria, A., Hunt, J. D., Kelm, O., Hung, R. J., Taniere, P., Brennan, P., Boffetta, P., Zaridze, D. G., and Hainaut, P. (2005) TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: Distinct patterns in never, former, and current smokers, Cancer Res. 65, 5076-5083. (Pubitemid 40827316)
25. Mascaux, C., Iannino, N., Martin, B., Paesmans, M., Berghmans, T., Dusart, M., Haller, A., Lothaire, P., Meert, A. P., Noel, S., Lafi tte, J. J., and Sculier, J. P. (2005) The role of RAS oncogene in survival of patients with lung cancer: A systematic review of the literature with metaanalysis, Br J Cancer 92, 131-139. (Pubitemid 40188446)
26. Linardou, H., Dahabreh, I. J., Kanaloupiti, D., Siannis, F., Bafaloukos, D., Kosmidis, P., Papadimitriou, C. A., and Murray, S. (2008) Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-Targeted agents: A systematic review and meta-Analysis of studies in advanced nonsmall-cell lung cancer and metastatic colorectal cancer, Lancet Oncol 9, 962-972.
27. Wong, D. W., Leung, E. L., So, K. K., Tam, I. Y., Sihoe, A. D., Cheng, L. C., Ho, K. K., Au, J. S., Chung, L. P., and Pik Wong, M. (2009) The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-Type EGFR and KRAS, Cancer 115, 1723-1733.
28. Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., Fulton, L., Fulton, R. S., Zhang, Q., Wendl, M. C., Lawrence, M. S., Larson, D. E., Chen, K., Dooling, D. J., Sabo, A., Hawes, A. C., Shen, H., Jhangiani, S. N., Lewis, L. R., Hall, O., Zhu, Y., Mathew, T., Ren, Y., Yao, J., Scherer, S. E., Clerc, K., Metcalf, G. A., Ng, B., Milosavljevic, A., Gonzalez-Garay, M. L., Osborne, J. R., Meyer, R., Shi, X., Tang, Y., Koboldt, D. C., Lin, L., Abbott, R., Miner, T. L., Pohl, C., Fewell, G., Haipek, C., Schmidt, H., Dunford-Shore, B. H., Kraja, A., Crosby, S. D., Sawyer, C. S., Vickery, T., Sander, S., Robinson, J., Winckler, W., Baldwin, J., Chirieac, L. R., Dutt, A., Fennell, T., Hanna, M., Johnson, B. E., Onofrio, R. C., Thomas, R. K., Tonon, G., Weir, B. A., Zhao, X., Ziaugra, L., Zody, M. C., Giordano, T., Orringer, M. B., Roth, J. A., Spitz, M. R., Wistuba, II, Ozenberger, B., Good, P. J., Chang, A. C., Beer, D. G., Watso, M. A., Ladanyi, M., Broderick, S., Yoshizawa, A., Travis, W. D., Pao, W., Province, M. A., Weinstock, G. M., Varmus, H. E., Gabriel, S. B., Lander, E. S., Gibbs, R. A., Meyerson, M., and Wilson, R. K. (2008) Somatic mutations affect key pathways in lung adenocarcinoma, Nature 455, 1069-1075.
29. Jones, P. A., and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer, Nat. Rev. Genet. 3, 415-428. (Pubitemid 34587077)
30. Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., Grimes, M. J., Harms, H. J., Tellez, C. S., Smith, T. M., Moots, P. P., Lechner, J. F., Stidley, C. A., and Crowell, R. E. (2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers, Cancer Res. 62, 2370-2377. (Pubitemid 34411720)
31. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. (1999) CpG island methylator phenotype in colorectal cancer, Proc. Natl. Acad. Sci. U S A 96, 8681-8686. (Pubitemid 29354851)
32. Issa, J. P. (2004) CpG island methylator phenotype in cancer, Nat Rev Cancer 4, 988-993.
33. Grady, W. M. (2007) CIMP and colon cancer gets more complicated, Gut 56, 1498-1500. (Pubitemid 350033183)
34. Suzuki, M., Shigematsu, H., Iizasa, T., Hiroshima, K., Nakatani, Y., Minna, J. D., Gazdar, A. F., and Fujisawa, T. (2006) Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer, Cancer 106, 2200-2207. (Pubitemid 43673242)
35. Liu, Z., Zhao, J., Chen, X. F., Li, W., Liu, R., Lei, Z., Liu, X., Peng, X., Xu, K., Chen, J., Liu, H., Zhou, Q. H., and Zhang, H. T. (2008) CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer, Lung cancer 62, 15-22.
36. Goto, Y., Shinjo, K., Kondo, Y., Shen, L., Toyota, M., Suzuki, H., Gao, W., An, B., Fujii, M., Murakami, H., Osada, H., Taniguchi, T., Usami, N., Kondo, M., Hasegawa, Y., Shimokata, K., Matsuo, K., Hida, T., Fujimoto, N., Kishimoto, T., Issa, J. P., and Sekido, Y. (2009) Epigenetic profi les distinguish malignant pleural mesothelioma from lung adenocarcinoma, Cancer Res. 69, 9073-9082.
37. Toyooka, S., Tokumo, M., Shigematsu, H., Matsuo, K., Asano, H., Tomii, K., Ichihara, S., Suzuki, M., Aoe, M., Date, H., Gazdar, A. F., and Shimizu, N. (2006) Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers, Cancer Res. 66, 1371-1375. (Pubitemid 43259916)
38. Dai, Z., Lakshmanan, R. R., Zhu, W. G., Smiraglia, D. J., Rush, L. J., Fruhwald, M. C., Brena, R. M., Li, B., Wright, F. A., Ross, P., Otterson, G. A., and Plass, C. (2001) Global methylation profi ling of lung cancer identifi es novel methylated genes, Neoplasia 3, 314-323. (Pubitemid 32801881)
39. Brena, R. M., Morrison, C., Liyanarachchi, S., Jarjoura, D., Davuluri, R. V., Otterson, G. A., Reisman, D., Glaros, S., Rush, L. J., and Plass, C. (2007) Aberrant DNA methylation of OLIG1, a novel prognostic factor in nonsmall cell lung cancer, PLoS medicine 4, e108.
40. Cameron, E. E., Bachman, K. E., Myohanen, S., Herman, J. G., and Baylin, S. B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer, Nat. Genet. 21, 103-107. (Pubitemid 29036293)
41. Shames, D. S., Girard, L., Gao, B., Sato, M., Lewis, C. M., Shivapurkar, N., Jiang, A., Perou, C. M., Kim, Y. H., Pollack, J. R., Fong, K. M., Lam, C. L., Wong, M., Shyr, Y., Nanda, R., Olopade, O. I., Gerald, W., Euhus, D. M., Shay, J. W., Gazdar, A. F., and Minna, J. D. (2006) A genome-wide screen for promoter methylation in lung cancer identifi es novel methylation markers for multiple malignancies, PLoS medicine 3, e486.
42. Zhong, S., Fields, C. R., Su, N., Pan, Y. X., and Robertson, K. D. (2007) Pharmacologic inhibition of epigenetic modifi cations, coupled with gene expression profi ling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer, Oncogene 26, 2621-2634. (Pubitemid 46632003)
43. Bibikova, M., Lin, Z., Zhou, L., Chudin, E., Garcia, E. W., Wu, B., Doucet, D., Thomas, N. J., Wang, Y., Vollmer, E., Goldmann, T., Seifart, C., Jiang, W., Barker, D. L., Chee, M. S., Floros, J., and Fan, J. B. (2006) Highthroughput DNA methylation profi ling using universal bead arrays, Genome Res 16, 383-393. (Pubitemid 43327509)
44. Christensen, B. C., Marsit, C. J., Houseman, E. A., Godleski, J. J., Longacker, J. L., Zheng, S., Yeh, R. F., Wrensch, M. R., Wiemels, J. L., Karagas, M. R., Bueno, R., Sugarbaker, D. J., Nelson, H. H., Wiencke, J. K., and Kelsey, K. T. (2009) Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profi les, Cancer Res. 69, 6315-6321.
45. Rauch, T., Wang, Z., Zhang, X., Zhong, X., Wu, X., Lau, S. K., Kernstine, K. H., Riggs, A. D., and Pfeifer, G. P. (2007) Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay, Proc. Natl. Acad. Sci. U S A 104, 5527-5532. (Pubitemid 47175714)
46. Rauch, T. A., Zhong, X., Wu, X., Wang, M., Kernstine, K. H., Wang, Z., Riggs, A. D., and Pfeifer, G. P. (2008) High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer, Proc. Natl. Acad. Sci. U S A 105, 252-257.
47. Fukasawa, M., Kimura, M., Morita, S., Matsubara, K., Yamanaka, S., Endo, C., Sakurada, A., Sato, M., Kondo, T., Horii, A., Sasaki, H., and Hatada, I. (2006) Microarray analysis of promoter methylation in lung cancers, J Hum. Genet. 51, 368-374.
48. Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., Jaffe, D. B., Gnirke, A., Jaenisch, R., and Lander, E. S. (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells, Nature 454, 766-770.
49. Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q. M., Edsall, L., Antosiewicz-Bourget, J., Stewart, R., Ruotti, V., Millar, A. H., Thomson, J. A., Ren, B., and Ecker, J. R. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences, Nature 462, 315-322.
50. Licchesi, J. D., Westra, W. H., Hooker, C. M., and Herman, J. G. (2008) Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung, Clin. Cancer Res. 14, 2570-2578.
51. Belinsky, S. A., Liechty, K. C., Gentry, F. D., Wolf, H. J., Rogers, J., Vu, K., Haney, J., Kennedy, T. C., Hirsch, F. R., Miller, Y., Franklin, W. A., Herman, J. G., Baylin, S. B., Bunn, P. A., and Byers, T. (2006) Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort, Cancer Res. 66, 3338-3344.
52. Schmiemann, V., Bocking, A., Kazimirek, M., Onofre, A. S., Gabbert, H. E., Kappes, R., Gerharz, C. D., and Grote, H. J. (2005) Methylation assay for the diagnosis of lung cancer on bronchial aspirates: A cohort study, Clin. Cancer Res. 11, 7728-7734. (Pubitemid 41611615)
53. Belinsky, S. A., Klinge, D. M., Dekker, J. D., Smith, M. W., Bocklage, T. J., Gilliland, F. D., Crowell, R. E., Karp, D. D., Stidley, C. A., and Picchi, M. A. (2005) Gene promoter methylation in plasma and sputum increases with lung cancer risk, Clin. Cancer Res. 11, 6505-6511. (Pubitemid 41338988)
54. Fujiwara, K., Fujimoto, N., Tabata, M., Nishii, K., Matsuo, K., Hotta, K., Kozuki, T., Aoe, M., Kiura, K., Ueoka, H., and Tanimoto, M. (2005) Identifi cation of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer, Clin. Cancer Res. 11, 1219-1225. (Pubitemid 40175774)
55. Tsou, J. A., Galler, J. S., Wali, A., Ye, W., Siegmund, K. D., Groshen, S., Laird, P. W., Turla, S., Koss, M. N., Pass, H. I., and Laird-Offringa, I. A. (2007) DNA methylation profile of 28 potential marker loci in malignant mesothelioma, Lung cancer 58, 220-230. (Pubitemid 47513257)
56. Toyooka, S., Pass, H. I., Shivapurkar, N., Fukuyama, Y., Maruyama, R., Toyooka, K. O., Gilcrease, M., Farinas, A., Minna, J. D., and Gazdar, A. F. (2001) Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma, Cancer Res. 61, 5727-5730. (Pubitemid 32769086)
57. Fischer, J. R., Ohnmacht, U., Rieger, N., Zemaitis, M., Stoffregen, C., Kostrzewa, M., Buchholz, E., Manegold, C., and Lahm, H. (2006) Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma, Lung cancer 54, 109-116.
58. Issa, J. P., and Kantarjian, H. M. (2009) Targeting DNA methylation, Clin. Cancer Res. 15, 3938-3946.
59. Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., Ellerton, J., Larson, R. A., Schiffer, C. A., and Holland, J. F. (2002) Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B, J. Clin. Oncol 20, 2429-2440. (Pubitemid 34525728)
60. Kantarjian, H., Issa, J. P., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., Helmer, R., 3rd, Shen, L., Nimer, S. D., Leavitt, R., Raza, A., and Saba, H. (2006) Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study, Cancer 106, 1794-1803.
61. Schrump, D. S., Fischette, M. R., Nguyen, D. M., Zhao, M., Li, X., Kunst, T. F., Hancox, A., Hong, J. A., Chen, G. A., Pishchik, V., Figg, W. D., Murgo, A. J., and Steinberg, S. M. (2006) Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura, Clin. Cancer Res. 12, 5777-5785. (Pubitemid 44629609)
62. Momparler, R. L., and Ayoub, J. (2001) Potential of 5-Aza-2 ¢ -deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer, Lung cancer 34 Suppl 4, S111-115.
63. Shen, L., Kantarjian, H., Guo, Y., Lin, E., Shan, J., Huang, X., Berry, D., Ahmed, S., Zhu, W., Pierce, S., Kondo, Y., Oki, Y., Jelinek, J., Saba, H., Estey, E., and Issa, J. P. (2010) DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes, J. Clin. Oncol 28, 605-613.
64. Appleton, K., Mackay, H. J., Judson, I., Plumb, J. A., McCormick, C., Strathdee, G., Lee, C., Barrett, S., Reade, S., Jadayel, D., Tang, A., Bellenger, K., Mackay, L., Setanoians, A., Schatzlein, A., Twelves, C., Kaye, S. B., and Brown, R. (2007) Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors, J. Clin. Oncol 25, 4603-4609. (Pubitemid 350035319)
65. Plumb, J. A., Strathdee, G., Sludden, J., Kaye, S. B., and Brown, R. (2000) Reversal of drug 2 ¢ -deoxy-5-Azacytidine-induced demethylation of the hMLH1 gene promoter, Cancer Res. 60, 6039-6044.
66. Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G., Otte, A. P., Rubin, M. A., and Chinnaiyan, A. M. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature 419, 624-629.
67. Kikuchi, J., Kinoshita, I., Shimizu, Y., Kikuchi, E., Konishi, J., Oizumi, S., Kaga, K., Matsuno, Y., Nishimura, M., and Dosaka-Akita, H. (2010) Distinctive expression of the polycomb group proteins Bmi1 polycomb ring fi nger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic signifi -cance, Cancer 116, 3015-3024.
68. Barlesi, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A., and Rodriguez, J. A. (2007) Global histone modifi cations predict prognosis of resected non small-cell lung cancer, J. Clin. Oncol 25, 4358-4364. (Pubitemid 350013840)
69. Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., Wong, K. K., Brandstetter, K., Wittner, B., Ramaswamy, S., Classon, M., and Settleman, J. (2010) A chromatin-mediated reversible drug-Tolerant state in cancer cell subpopulations, Cell 141, 69-80.
70. Juergens R. A., Vendetti F., Coleman B., Sebree R. S., Rudek M. A., Belinsky S., Brock M., Herman J., Baylin S., Rudin C. M. (2009) Interim analysis of a phase II trial of 5-Azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC), J. Clin. Oncol 27:15s, abstr 8055.
71. Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., Harris, C. C., Lichti, C. F., Townsend, R. R., Fulton, R. S., Dooling, D. J., Koboldt, D. C., Schmidt, H., Zhang, Q., Osborne, J. R., Lin, L., O'Laughlin, M., McMichael, J. F., Delehaunty, K. D., McGrath, S. D., Fulton, L. A., Magrini, V. J., Vickery, T. L., Hundal, J., Cook, L. L., Conyers, J. J., Swift, G. W., Reed, J. P., Alldredge, P. A., Wylie, T., Walker, J., Kalicki, J., Watson, M. A., Heath, S., Shannon, W. D., Varghese, N., Nagarajan, R., Westervelt, P., Tomasson, M. H., Link, D. C., Graubert, T. A., DiPersio, J. F., Mardis, E. R., and Wilson, R. K. (2010) DNMT3A mutations in acute myeloid leukemia, N. Engl. J. Med. 363, 2424-2433.
72. Morin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., Yap, D., Humphries, R. K., Griffith, O. L., Shah, S., Zhu, H., Kimbara, M., Shashkin, P., Charlot, J. F., Tcherpakov, M., Corbett, R., Tam, A., Varhol, R., Smailus, D., Moksa, M., Zhao, Y., Delaney, A., Qian, H., Birol, I., Schein, J., Moore, R., Holt, R., Horsman, D. E., Connors, J. M., Jones, S., Aparicio, S., Hirst, M., Gascoyne, R. D., and Marra, M. A. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin, Nat. Genet. 42, 181-185.
73. Kim, J. S., Kim, J. W., Han, J., Shim, Y. M., Park, J., and Kim, D. H. (2006) Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer, Cancer Res. 66, 4049-4054.
74. Yanagawa, N., Tamura, G., Oizumi, H., Takahashi, N., Shimazaki, Y., and Motoyama, T. (2003) Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers, Cancer Sci 94, 589-592. (Pubitemid 36975012)
75. Helmbold, P., Lahtz, C., Herpel, E., Schnabel, P. A., and Dammann, R. H. (2009) Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer, Eur J Cancer 45, 2207-2211.
76. Shivapurkar, N., Stastny, V., Suzuki, M., Wistuba, II, Li, L., Zheng, Y., Feng, Z., Hol, B., Prinsen, C., Thunnissen, F. B., and Gazdar, A. F. (2007) Application of a methylation gene panel by quantitative PCR for lung cancers, Cancer Lett 247, 56-71. (Pubitemid 44959413)
77. Hawes, S. E., Stern, J. E., Feng, Q., Wiens, L. W., Rasey, J. S., Lu, H., Kiviat, N. B., and Vesselle, H. (2010) DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type, Lung cancer 69, 172-179.
78. Buckingham, L., Penfi eld Faber, L., Kim, A., Liptay, M., Barger, C., Basu, S., Fidler, M., Walters, K., Bonomi, P., and Coon, J. (2010) PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients, Int J Cancer 126, 1630-1639.
79. Palmisano, W. A., Crume, K. P., Grimes, M. J., Winters, S. A., Toyota, M., Esteller, M., Joste, N., Baylin, S. B., and Belinsky, S. A. (2003) Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers, Cancer Res. 63, 4620-4625. (Pubitemid 36951039)
80. Koga, T., Takeshita, M., Yano, T., Maehara, Y., and Sueishi, K. (2010) CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer, Int J Cancer 128, 1009-1017.
81. Mizuno, K., Osada, H., Konishi, H., Tatematsu, Y., Yatabe, Y., Mitsudomi, T., Fujii, Y., and Takahashi, T. (2002) Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers, Oncogene 21, 2328-2333. (Pubitemid 34407292)
82. Zochbauer-Muller, S., Fong, K. M., Maitra, A., Lam, S., Geradts, J., Ashfaq, R., Virmani, A. K., Milchgrub, S., Gazdar, A. F., and Minna, J. D. (2001) 5 CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer, Cancer Res. 61, 3581-3585. (Pubitemid 32694965)
83. Toyooka, S., Toyooka, K. O., Maruyama, R., Virmani, A. K., Girard, L., Miyajima, K., Harada, K., Ariyoshi, Y., Takahashi, T., Sugio, K., Brambilla, E., Gilcrease, M., Minna, J. D., and Gazdar, A. F. (2001) DNA methylation profi les of lung tumors, Mol. Cancer Ther 1, 61-67.
84. Marsit, C. J., Kim, D. H., Liu, M., Hinds, P. W., Wiencke, J. K., Nelson, H. H., and Kelsey, K. T. (2005) Hypermethylation of RASSF1A and BLU tumor suppressor genes in nonsmall cell lung cancer: Implications for tobacco smoking during adolescence, Int J Cancer 114, 219-223. (Pubitemid 40194289)
85. Agathanggelou, A., Dallol, A., Zochbauer-Muller, S., Morrissey, C., Honorio, S., Hesson, L., Martinsson, T., Fong, K. M., Kuo, M. J., Yuen, P. W., Maher, E. R., Minna, J. D., and Latif, F. (2003) Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers, Oncogene 22, 1580-1588. (Pubitemid 36390607)
86. Zochbauer-Muller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., and Minna, J. D. (2001) Aberrant promoter methylation of multiple genes in non-small cell lung cancers, Cancer Res. 61, 249-255. (Pubitemid 32095725)
87. Marsit, C. J., Liu, M., Nelson, H. H., Posner, M., Suzuki, M., and Kelsey, K. T. (2004) Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival, Oncogene 23, 1000-1004. (Pubitemid 38250946)
88. Lee, M. N., Tseng, R. C., Hsu, H. S., Chen, J. Y., Tzao, C., Ho, W. L., and Wang, Y. C. (2007) Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer, Clin. Cancer Res. 13, 832-838. (Pubitemid 46340356)
89. Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C., Zangemeister-Wittke, U., and Stahel, R. (2003) Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation, Cell death and differentiation 10, 356-364. (Pubitemid 36582373)
90. Shivapurkar, N., Toyooka, S., Eby, M. T., Huang, C. X., Sathyanarayana, U. G., Cunningham, H. T., Reddy, J. L., Brambilla, E., Takahashi, T., Minna, J. D., Chaudhary, P. M., and Gazdar, A. F. (2002) Differential inactivation of caspase-8 in lung cancers, Cancer Biol Ther 1, 65-69.
91. Virmani, A., Rathi, A., Sugio, K., Sathyanarayana, U. G., Toyooka, S., Kischel, F. C., Tonk, V., Padar, A., Takahashi, T., Roth, J. A., Euhus, D. M., Minna, J. D., and Gazdar, A. F. (2003) Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer, Int J Cancer 106, 198-204. (Pubitemid 36835171)
92. Marsit, C. J., Zheng, S., Aldape, K., Hinds, P. W., Nelson, H. H., Wiencke, J. K., and Kelsey, K. T. (2005) PTEN expression in non-smallcell lung cancer: Evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration, Human pathology 36, 768-776. (Pubitemid 41112032)
93. Dammann, R., Takahashi, T., and Pfeifer, G. P. (2001) The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas, Oncogene 20, 3563-3567. (Pubitemid 32619409)
94. Lai, J. C., Cheng, Y. W., Chiou, H. L., Wu, M. F., Chen, C. Y., and Lee, H. (2005) Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer, Int J Cancer 117, 974-980. (Pubitemid 41688572)
95. He, B., You, L., Uematsu, K., Zang, K., Xu, Z., Lee, A. Y., Costello, J. F., McCormick, F., and Jablons, D. M. (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer, Proc. Natl. Acad. Sci. U S A 100, 14133-14138. (Pubitemid 37499203)
96. Dammann, R., Strunnikova, M., Schagdarsurengin, U., Rastetter, M., Papritz, M., Hattenhorst, U. E., Hofmann, H. S., Silber, R. E., Burdach, S., and Hansen, G. (2005) CpG island methylation and expression of tumour-Associated genes in lung carcinoma, Eur J Cancer 41, 1223-1236. (Pubitemid 40725582)
97. Kikuchi, S., Yamada, D., Fukami, T., Maruyama, T., Ito, A., Asamura, H., Matsuno, Y., Onizuka, M., and Murakami, Y. (2006) Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma, Cancer 106, 1751-1758.
98. Heller, G., Fong, K. M., Girard, L., Seidl, S., End-Pfutzenreuter, A., Lang, G., Gazdar, A. F., Minna, J. D., Zielinski, C. C., and Zochbauer-Muller, S. (2006) Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas, Oncogene 25, 959-968. (Pubitemid 43237714)
99. Marsit, C. J., Houseman, E. A., Christensen, B. C., Eddy, K., Bueno, R., Sugarbaker, D. J., Nelson, H. H., Karagas, M. R., and Kelsey, K. T. (2006) Examination of a CpG island methylator phenotype and implications of methylation profi les in solid tumors, Cancer Res. 66, 10621-10629. (Pubitemid 44799786)
100. Suzuki, M., Wada, H., Yoshino, M., Tian, L., Shigematsu, H., Suzuki, H., Alaa, M., Tamura, H., Fujiwara, T., Nagato, K., Motohashi, S., Moriya, Y., Hoshino, H., Yoshida, S., Shibuya, K., Hiroshima, K., Nakatani, Y., and Yoshino, I. (2010) Molecular characterization of chronic obstructive pulmonary disease-related nonsmall cell lung cancer through aberrant methylation and alterations of EGFR signaling, Ann Surg. Oncol. 17, 878-888.